Amy Bachrodt, SVP, Finance at Maze Therapeutics, Inc. (MAZE), sold 10,000 shares at $45.52 ($455K) on 2026-01-22, disclosed to the SEC on 2026-01-26.
Open-market sale of $455k MAZE by SVP, Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.52 | 5,000 | $228K | 50.0% |
| 2 | $45.52 | 5,000 | $228K | 50.0% |
| Total | $45.52 avg | 10,000 | $455K | 100% |
| Filing → |
| MAZE | SELL | 2026-02-04 | $452K | — | Filing → |
| MAZE | SELL | 2026-01-06 | $392K | — | Filing → |
| MAZE | SELL | 2025-12-31 | $606K | — | Filing → |